Researchers Map Paths to Cancer Drug Resistance
A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop cancer drug resistance to otherwise lethal therapies. By mapping the specific steps that cells of melanoma, breast cancer, and a ...